VORAPAXAR: 189 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
189
Total FAERS Reports
12 (6.3%)
Deaths Reported
45
Hospitalizations
189
As Primary/Secondary Suspect
6
Life-Threatening
5
Disabilities
May 8, 2014
FDA Approved
Discontinued
Status
Active Ingredient: VORAPAXAR SULFATE · FDA Application: 204886 ·
Patent Expires: Dec 23, 2027 · First Report: 2010 · Latest Report: 20220804
What Are the Most Common VORAPAXAR Side Effects?
#1 Most Reported
Gastrointestinal haemorrhage
15 reports (7.9%)
#2 Most Reported
Epistaxis
11 reports (5.8%)
#3 Most Reported
Drug dose omission
8 reports (4.2%)
All VORAPAXAR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Gastrointestinal haemorrhage | 15 | 7.9% | 1 | 7 |
| Epistaxis | 11 | 5.8% | 0 | 1 |
| Chest pain | 8 | 4.2% | 0 | 4 |
| Death | 8 | 4.2% | 8 | 0 |
| Drug dose omission | 8 | 4.2% | 0 | 1 |
| Haemorrhage | 7 | 3.7% | 0 | 2 |
| Dyspnoea | 6 | 3.2% | 0 | 4 |
| Haemoglobin decreased | 5 | 2.7% | 0 | 3 |
| Malaise | 5 | 2.7% | 1 | 1 |
| Rash | 5 | 2.7% | 0 | 1 |
Who Reports VORAPAXAR Side Effects? Age & Gender Data
Gender: 30.6% female, 69.4% male. Average age: 66.2 years. Most reports from: US. View detailed demographics →
Is VORAPAXAR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 2 | 0 | 0 |
| 2014 | 4 | 1 | 0 |
| 2015 | 27 | 2 | 8 |
| 2016 | 20 | 0 | 8 |
| 2017 | 17 | 1 | 7 |
| 2018 | 15 | 4 | 4 |
| 2019 | 1 | 0 | 0 |
| 2022 | 1 | 0 | 0 |
What Is VORAPAXAR Used For?
VORAPAXAR vs Alternatives: Which Is Safer?
VORAPAXAR vs VORASIDENIB
VORAPAXAR vs VORETIGENE NEPARVOVEC-RZYL
VORAPAXAR vs VORICONAZOLE
VORAPAXAR vs VORINOSTAT
VORAPAXAR vs VORTIOXETINE
VORAPAXAR vs VORTIOXETINE HYDROBROMIDE
VORAPAXAR vs VOSORITIDE
VORAPAXAR vs VOTRIENT
VORAPAXAR vs VOXELOTOR
VORAPAXAR vs VUTRISIRAN
Official FDA Label for VORAPAXAR
Official prescribing information from the FDA-approved drug label.